Skip to main content
. 2013 Dec 10;4(1):47–80. doi: 10.7150/thno.7447

Fig 3.

Fig 3

A) Depiction of the basic components of an imaging agent comprising a vector for specific binding, pharmacokinetic modifier, and the complex of the chelator moiety with a radiometal; B) Drawing of the interaction of the agent, either imaging if labelled with 68Ga (left) or radiotherapetic if labelled with 177Lu (right), with the cell receptor.